Molly Henderson, CFO and CBO at Phathom Pharmaceuticals, Inc. (PHAT), sold 3,678 shares at $4.55 ($17K) on 2025-04-07, disclosed to the SEC on 2025-04-08.
Seasonal sale ($17k) by CFO and CBO — this insider has traded PHAT in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| PHAT | SELL | 2024-07-17 | $51K | — | Filing → |
| PHAT | SELL | 2024-04-10 | $38K | — | Filing → |
| PHAT | SELL | 2024-01-22 | $49K | — | Filing → |